Looks like:
Great product +
Great Management +
Sturdy financial situation =
Good investment with acceptable risk parameters.
Thanks for sharing all the info. With the KOL's so effusive, I am sure something would have slipped out at HRS if another company had a truly competitive late-stage product at the stage of roll out that BSGM is at now.
I will definitely be curious to hear more about other potential uses being explored beyond the cardio ablation area. Do the guts of the processors/software stay basically the same and it is only a matter of the BSGM engineers figuring out the physical inputs needed for other organs?